Abeona Therapeutics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.About ABEO
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).
CEOVishwas Seshadri
CEOVishwas Seshadri
Employees90
Employees90
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1974
Founded1974
Employees90
Employees90
ABEO Key Statistics
Market cap66.13M
Market cap66.13M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume255.65K
Average volume255.65K
High today—
High today—
Low today—
Low today—
Open price$3.85
Open price$3.85
Volume0.00
Volume0.00
52 Week high$17.50
52 Week high$17.50
52 Week low$2.70
52 Week low$2.70
ABEO Earnings
-$4.50
-$3.00
-$1.50
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 30, Pre-Market
ActualExpected Mar 30, Pre-Market